We are excited to announce that Colonis’ Managing Director, Alan Knox, has been elected as the Vice-Chair of the Value Added Medicines Group at Medicines for Europe.  

Speaking about his new position, Alan said, “I am delighted to be elected as Vice-Chair to the VAM sector of Medicines for Europe. I look forward to working with my colleagues to bring more companies and countries to this exciting focus area and to support a sustainable market model that incentivises Research & Development and access to value added medicines in Europe”. 

Alan brings his knowledge of value added medicines from Colonis to this new venture, continuing to drive better health outcomes for patients across Europe. Using his experience of launching repurposed and reformulated medicines, Alan is further supporting Colonis’ journey to make medicines more manageable for patients and healthcare professionals. 

We look forward to the impact of Alan’s new role. 

To find out more about the rest of our team, click here.

GB-CPL-0-338
December 2025